Forest strives to positively impact the health and quality of life of patients through
the development of innovative prescription drug therapies.
From molecule to the medicine cabinet
Our scientific subsidiary, Forest Research Institute, Inc. (FRI), drives the development
of our novel pharmaceutical agents and provides medical and scientific support for
currently marketed products.
The growth of Forest as a company is driven by our R&D productivity. By having
steadily increased our R&D investment and deepened our pool of talent over the
past decade, Forest has strengthened its ability to license innovative new products
earlier in the development cycle and across a wider span of therapeutic areas. Once
a compound enters our pipeline, we collaborate closely with
our partner to formulate and implement a development plan that will maximize
the potential benefits of the drug.
Read further to learn more about our R&D pipeline.
Please click here to learn about our Post Marketing Commitments.